The Throat Cancer Report 2025 – For Strategy Officers and Market Intelligence Teams

July 03, 2025 06:16 PM BST | By EIN Presswire
 The Throat Cancer Report 2025 – For Strategy Officers and Market Intelligence Teams
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, July 3, 2025 /EINPresswire.com/ -- How Big Is The Global Throat Cancer Market Expected To Grow?
The throat cancer market size has grown significantly in recent years. An increase from $2.25 billion in 2024 to an estimated $2.45 billion in 2025, with a compound annual growth rate CAGR of 9.0%, reflects this robust growth. Several factors have contributed to this growth, including an uptick in the smoking population, rising incidents of alcohol abuse, increasing human papillomavirus HPV infections, a growing prevalence of gastroesophageal reflux disease, and increasing levels of urban air pollution.

The surge in the smoking population is specifically notable for propelling the growth of the throat cancer market. As a stark reminder of the severe health risks associated with smoking, throat cancer underlines the urgent need for public awareness and preventive measures to curb its prevalence in smoking populations. This need becomes more significant considering the observations from a study by the European Respiratory Society ERS, that revealed a steep rise in smoking rates among young people, increasing from 22.5% of respondents smoking in 2022 to 40.1% in 2024.

What Is Its Annual Growth Rate?
Looking forward, the throat cancer market size is projected to witness robust growth, reaching $3.42 billion in 2029 at a CAGR of 8.7%. The forecast growth can be attributed to various factors, including the rise in demand for personalized medicine, increasing adoption of tele-oncology and diagnostic tools, the surge in genetic profiling and biomarker adoption, the increasing popularity of e-cigarettes and vaping, and the growing rates of sedentary lifestyles and obesity.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24722&type=smp

What Is Driving The Growth Of The Throat Cancer Market?
Key innovations are expected to shape the healthcare landscape in the forecast period. This includes advancements in treatment techniques, the inclusion of novel technologies in diagnostic equipment, the development of new drugs and therapies, the integration of artificial intelligence, and machine learning in predictive diagnostics, and the integration of speech therapy with digital platforms.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/throat-cancer-global-market-report
Which Leading Companies Are Driving The Growth Of The Throat Cancer Market Share?

Major players in the throat cancer market include Pfizer Inc., Roche Holding AG, Merck and Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories, Biocon Ltd., Coherus BioSciences Inc., Inovio Pharmaceuticals Inc., Boston Biomedical Inc., Shanghai Sunway Biotech Co. Ltd., Odon Life Sciences.

What Are The Key Trends Of The Throat Cancer Market?
Notably, these key industry players are directing their efforts towards developing innovative therapies, such as immuno-oncology drugs, to enhance treatment efficacy and improve patient survival outcomes. For example, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab for treating nasopharyngeal carcinoma, a unique form of throat cancer, in November 2024.
Toripalimab leverages the power of immune checkpoint inhibition, targeting the PD-1 receptor, allowing the body's immune system to recognize and attack cancer cells better. This novel treatment opens up new options for patients suffering from a rare and aggressive form of cancer that traditionally had limited therapeutic choices.

How Is The Global Throat Cancer Market Segmented?
The categories covered in this report include:
1 By Type: Pharyngeal Cancer, Laryngeal Cancer
2 By Treatments: Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Antimetabolites, Platinum Derivatives, Plant Derivatives, Nitrogen Mustards, Antibiotics, Other Treatments
3 By End-User: Hospitals, Cancer Research Institutes, Multispecialty Clinics, Ambulatory Surgical Centers

Under pharyngeal cancer: Oropharyngeal Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer are covered, while Glottic Cancer, Supraglottic Cancer, Subglottic Cancer are included under laryngeal cancer.

What Are The Leading Region In The Throat Cancer Market?
In terms of geographic distribution, North America was the largest region in the throat cancer market in 2024. However, the report also covers regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pancreatic Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Breast Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Learn more about The Business Research Company, a company that offers comprehensive, data-rich research and insights. With over 15000+ reports from 27 industries covering 60+ geographies, stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 7882 955267
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next